Description
Ixazomib
Each LuciXaz capsule contains: 5.7mg lxazomib citrate equivalent to lxazomib … 4mg
INDICATION
LuciXaz is a proteasome inhibitor indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.
DOSAGE AND USE
Recommended starting dose of 4 mg taken orally on Days 1, 8, and 15 of a 28 -day cycle. Dose should be taken at least one hour before or at least two hours after food. The capsule should be swallowed whole & not chewed or crushed.
STORAGE
In a dry place and store at 20°C to 25°C.
MANUFACTURED AND MARKETED BY
LUCIUS PHARMACEUTICALS(LAO) CO., LTD No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos
WARNING
Keep medicine out of the reach of Children. Do not administered LuciXaz in Pregnancy and Lactation patient treatment.
Reviews
There are no reviews yet.